Update on Predicting Severe Hyperbilirubinemia and Bilirubin Neurotoxicity Risks in Neonates.
Curr Pediatr Rev
Extreme hyperbilirubinemia and kernicterus, though rare, continue to occur despite the adoption of universal screening. Unless they are known to have glucose-6-phosphate dehydrogenase deficiency, infants who currently develop kernicterus in high resource countries are often otherwise healthy newborns discharged from the well-baby nursery. In this review, we highlight risk factors that increase the risk of a newborn ≥35 weeks gestational age developing severe hyperbilirubinemia, as well as the risk factors that increase the hyperbilirubinemic infant's risk of kernicterus.
Chang PW, Newman TB, Maisels MJ. Update on Predicting Severe Hyperbilirubinemia and Bilirubin Neurotoxicity Risks in Neonates. Curr Pediatr Rev. 2017;13(3):181-187. doi: 10.2174/1573396313666170123151408. PMID: 28117009.